9/03 Cybernics Medical and Healthcare Innovations contributing to a Super-Aging Society
TBIP is honored to invite Professor Yoshiyuki Sankai, a professor at the University of Tsukuba and the Chairman and CEO of CYBERDYNE Inc., to give a lecture at our center. We warmly welcome everyone to attend.
Date and Time:
Tuesday, September 3, 2024, 10:30-12:00
Location: Conference Room E249, Biotechnology Center (National Biotechnology Research Park, Building E)
Lecture Title:
Cybernics Medical and Healthcare Innovations Contributing to a Super-Aging Society: Toward a Partnership between Japan and Taiwan
Important Notes:
To respect the speaker’s intellectual property, photography, video recording, and audio recording are prohibited during the lecture.
Speaker Profile:
Professor Yoshiyuki Sankai is currently a professor at the University of Tsukuba, Executive Research Director of the Cybernics Research Center at the University of Tsukuba, Director of the F-MIRAI Center (established by Toyota), Chairman and CEO of CYBERDYNE Inc., and a project leader for the Cabinet Office's Cross-ministerial Strategic Innovation Promotion Program (SIP). He is a pioneer and entrepreneur in the field of Japanese exoskeletons, specifically the Hybrid Assistive Limb (HAL).
Professor Sankai leads CYBERDYNE in developing the wearable robot HAL (Hybrid Assistive Limb), which integrates with the human nervous system, creating a new control industry that fuses 'human-machine interaction.'
Due to his highly innovative research achievements, Professor Sankai holds a prestigious socio-economic position in Japan. He has led several significant projects initiated by the Cabinet Office of Japan, including the FIRST Program and the ImPACT Program, and has served as a business director for the Ministry of Education, Culture, Sports, Science and Technology's Regional Innovation Ecosystem Construction Program. He is also a member of various robotics and precision medicine associations. Currently, Professor Sankai is a member of the Robotics Society of Japan (RSJ) and the Society of Instrument and Control Engineers (SICE). In 2021, he was elected as an international member of the Royal Swedish Academy of Engineering Sciences (IVA).
Lecture Overview:
As societies move toward super-aging, the care of the elderly and the reduction of the labor force have become primary social issues.
In response, Professor Yoshiyuki Sankai founded CYBERDYNE Inc., and for many years, he has developed the 'Cybernics Medical and Healthcare Innovation System,' which integrates interdisciplinary expertise from the biological and cellular levels to robotics technology, creating the Cybernics technology that merges the human body, AI robots, and information systems.
The core of the Cybernics system is the wearable HAL (Hybrid Assistive Limb) robot. HAL connects to the bioelectrical signals of the brain's nervous system, allowing users to control the robot to assist their limb movements based on personal intentions, aiding patients with mobility impairments due to illness in improving their quality of life.
Moreover, HAL can monitor physiological data such as electrocardiograms, brain waves, body temperature, and blood oxygen levels and transmit the data to doctors and caregivers for real-time health management. Thus, the Cybernics system enables early detection and prevention, effective treatment, and post-treatment maintenance and improvement. In recent years, CYBERDYNE has also collaborated with several cell therapy companies to enhance the effectiveness of cell therapy for patients using HAL.
Currently, the Cybernics 'human-machine interaction' industry has been promoted in over 20 countries, including Japan, the United States, Europe, Asia, and the Middle East. In 2024, the National Neuro-Robotics and Cybernics Center in Malaysia will be officially inaugurated.
Professor Yoshiyuki Sankai's visit to Taiwan and this lecture aim to promote collaboration between Japan and Taiwan in the development of Cybernics innovation systems to contribute to the well-being of Taiwan's aging population.
Contact Person for the Event: Ms. Yeh, Biotechnology Center (02) 7700-3800 #5155
